Showing results (51-60 of 272) with videos related to
Sort By:
Pageof 28
Blood|September 1, 1988
Prominent expansion of circulating lymphocytes bearing gamma T-cell receptors, with preferential expression of variable gamma genes after allogeneic bone marrow transplantationE Vilmer, F Triebel, V David, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Combination of interleukin-2 and gamma interferon in metastatic renal cell carcinomaB Escudier, F Farace, E Angevin, et al.International Journal of Cancer|July 17, 1997
In situ T-cell responses in a primary regressive melanoma and subsequent metastases: a comparative analysisG Carcelain, N Rouas-Freiss, E Zorn, et al.Blood|October 15, 1994
In vivo T-cell clonal amplification at time of acute graft-versus-host diseaseP Y Dietrich, A Caignard, A Lim, et al.Cancer Research|March 1, 1994
Evidence for T-cell clonal expansion in a patient with squamous cell carcinoma of the head and neckA Caignard, P Y Dietrich, V Morand, et al.Blood|November 1, 1992
Analysis of T-cell receptor variability in transplanted patients with acute graft-versus-host diseaseP Y Dietrich, A Caignard, A Diu, et al.European Journal of Immunology|March 4, 1999
A natural cytotoxic T cell response in a spontaneously regressing human melanoma targets a neoantigen resulting from a somatic point mutationE Zorn, T HercendEuropean Journal of Immunology|March 4, 1999
A MAGE-6-encoded peptide is recognized by expanded lymphocytes infiltrating a spontaneously regressing human primary melanoma lesionE Zorn, T HercendThe Journal of Experimental Medicine|June 1, 1986
Natural killer clones derived from fetal (25 wk) blood. Probing the human T cell receptor with WT31 monoclonal antibodyA Nowill, P Moingeon, A Ythier, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1983
Inhibiton of IL 2 production after human allogeneic bone marrow transplantationO Azogui, E Gluckman, D FradeliziPageof 28